Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) can lead to significant weight loss and improve blood sugar control in ...

Naim Alkhouri, MD, spoke to the potential for glucagon-like peptide-1 (GLP-1) receptor agonists to transform the treatment ...

Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) can lead to significant weight loss and improve blood sugar control in adults with severe mental illness, as well as having positive effects on ...

Findings showed a 13.6% reduction in body weight in the semaglutide 25mg group compared with a 2.2% reduction in the placebo group.

Novo Nordisk's collaboration with telehealth providers offers semaglutide at $499/month, enhancing access for self-paying ...

They’ve all been used to describe effects of the rapid weight loss that can come from taking glucagon-like peptide-1 receptor agonists like semaglutide, which is in Ozempic. But such weight loss ...

Metamorphx is emerging as a leading natural GLP-1 alternative for weight loss in 2025. With prescription options like semaglutide (Ozempic, Wegovy) becoming cost-prohibitive or unavailable for ...

Glucagon-like peptide-1 receptor agonists ... Tirzepatide, a dual GLP-1/gastric inhibitory polypeptide (GIP) receptor agonist, and semaglutide, a GLP-1RA, are used to treat diabetes.

GLP-1 medications like Ozempic may help reduce alcohol cravings and support recovery—especially when combined with therapy and used to treat coexisting conditions.

It's no surprise that this is one of the most hotly contested therapeutics races of the decade: Last year, the global glucagon-like peptide-1 (GLP-1 ... has an oral semaglutide drug, Rybelsus ...

2 If approved, Wegovy® would become the first oral formulation of a GLP-1 indicated for chronic weight management. "We are entering a new era of obesity care where patients want individualized ...

2 If approved, Wegovy® would become the first oral formulation of a GLP-1 indicated ... up period.1,3 In total, 307 participants were randomized 2:1 ratio to once-daily oral semaglutide 25 ...